GSK3B and frontotemporal dementia: Interestingly, Alzheimer’s disease and FTD linked Tau which forms the neurofibrillary tangle pathology in these diseases may also activate GSK3β to disrupt the VAPB-PTPIP51 interaction and ER-mitochondria signaling functions (Fig. 3) [90, 100].